What Is Restless Legs Syndrome?
Restless Legs Syndrome (RLS), also known as Willis-Ekbom disease, is a sensorimotor neurologic disorder characterized by an irresistible urge to move the legs, generally accompanied by uncomfortable and unpleasant sensations in the lower extremities.
Symptoms follow a marked circadian pattern: they appear or worsen during rest and inactivity, especially at the end of the day and at night, and are relieved by movement. This pattern leads to significant sleep disturbance, with RLS being one of the most common causes of chronic insomnia.
RLS is classified as primary (idiopathic), with a strong genetic component, or secondary, associated with conditions such as iron deficiency, renal failure, pregnancy, peripheral neuropathy, and use of certain medications. The primary form is responsible for most cases.
Circadian Pattern
Symptoms worsen at night and during rest. This pattern is so consistent that it is a mandatory diagnostic criterion.
Dopaminergic Dysfunction
The central mechanism involves dysfunction of the dopaminergic system and iron metabolism in the central nervous system.
Impact on Sleep
RLS is one of the most frequent causes of insomnia. More than 80% of patients show periodic limb movements during sleep.
Epidemiology
RLS affects 5-10% of adults in Western countries and is less prevalent in Asian populations (1-3%). It is more common in women, and prevalence increases with age. Despite being common, RLS is often underdiagnosed — many patients never mention the symptoms to a physician or receive incorrect diagnoses.
Pathophysiology
Two central mechanisms converge in RLS pathophysiology: dopaminergic dysfunction and iron deficiency in the central nervous system. These two factors are intimately related, since iron is an essential cofactor for the enzyme tyrosine hydroxylase, necessary for dopamine synthesis.
Neuroimaging studies show reduced iron in the substantia nigra and red nucleus of RLS patients, even when serum iron and ferritin levels are normal. Brain iron deficiency compromises dopamine production and D2 dopaminergic receptor function.

The A11 dopaminergic system (diencephalic-spinal projections) is particularly relevant. These dopaminergic neurons of the posterior hypothalamus modulate the excitability of sensory and motor pathways in the spinal cord. Their dysfunction leads to disinhibition of these pathways, causing the abnormal sensations and the urge to move. The circadian pattern of symptoms correlates with the natural circadian variation of dopamine, which reaches its lowest levels at night.
SECONDARY CAUSES OF RLS
| CONDITION | MECHANISM | RLS PREVALENCE |
|---|---|---|
| Iron deficiency | Reduced dopamine synthesis | Proportional to degree of deficiency |
| Chronic renal failure | Accumulation of uremic toxins + iron deficiency | 20-60% of patients on dialysis |
| Pregnancy | Relative iron deficiency + hormonal alterations | 10-25%, especially in 3rd trimester |
| Peripheral neuropathy | Lesion of small sensory fibers | 5-20% of patients with neuropathy |
| Medications (antidepressants, antipsychotics) | Blockade of dopaminergic receptors | Variable depending on medication |
Symptoms
RLS symptoms are often hard to describe. Patients use varied terms: tingling, itching, burning, a sensation of "insects crawling", "deep restlessness", or "vague discomfort" in the legs. The core feature is the irresistible urge to move the legs.
Characteristic Symptoms of RLS
- 01
Irresistible urge to move the legs
The cardinal symptom. Often accompanied by uncomfortable sensations, but can occur as isolated motor urgency.
- 02
Worsens during rest and inactivity
Symptoms appear when lying down, sitting, or staying still. Classes, movie theaters, flights, and bed rest are typical triggers.
- 03
Relief with movement
Walking, stretching, massaging, or moving the legs temporarily relieves symptoms. Relief is immediate but transient.
- 04
Worsens at night
Consistent circadian pattern. Symptoms are most intense between 10 PM and 4 AM. May be minimal or absent in the morning.
- 05
Periodic limb movements (PLMS)
Repetitive ankle, knee, and hip flexion movements during sleep, occurring in >80% of patients with RLS. Fragments sleep.
- 06
Insomnia
Difficulty falling asleep is the most common complaint. Daytime fatigue, irritability, and cognitive impairment follow.
Diagnosis
The diagnosis of RLS is exclusively clinical, based on the criteria of the International Restless Legs Syndrome Study Group (IRLSSG). There is no laboratory or imaging test that confirms the diagnosis. Complementary tests are used to identify secondary causes and exclude differential diagnoses.
🏥IRLSSG Diagnostic Criteria (Revised 2014)
Fonte: Allen et al., 2014 — International Restless Legs Syndrome Study Group
Five Essential Criteria (All Mandatory)
All five criteria must be met- 1.1. Irresistible urge to move the legs, usually accompanied by uncomfortable sensations
- 2.2. Symptoms begin or worsen during rest or inactivity
- 3.3. Symptoms are partially or totally relieved by movement
- 4.4. Symptoms occur exclusively or worsen at evening or night
- 5.5. The above symptoms are not better explained by another medical or behavioral condition
Recommended Complementary Tests
- 1.Serum ferritin and transferrin saturation (ferritin < 75 ng/mL suggests iron deficiency contributing to RLS)
- 2.Complete blood count (exclude anemia)
- 3.Renal function (exclude renal failure)
- 4.Glucose/HbA1c (diabetic neuropathy)
- 5.TSH (thyroid disorders)
- 6.Polysomnography (if diagnosis is uncertain or sleep apnea is suspected)
DIFFERENTIAL DIAGNOSIS
| CONDITION | HOW TO DIFFERENTIATE FROM RLS |
|---|---|
| Nocturnal cramps | Painful, visible muscle contraction; not relieved by continuous movement |
| Peripheral neuropathy | Constant, non-circadian symptoms; sensory deficit on examination |
| Drug-induced akathisia | Generalized restlessness (not just legs); temporal link to medication |
| Venous insufficiency | Heaviness and evening edema; worsens with standing, improves with elevation |
| Vascular claudication | Pain on walking, relieved by rest (opposite of RLS) |
| Anxiety | Generalized restlessness; no circadian pattern; no localized uncomfortable sensations |
Differential Diagnosis
RLS is often underdiagnosed or confused with other conditions that cause nocturnal leg discomfort. Differential diagnosis is essential because treatment differs substantially between conditions.
DIAGNÓSTICO DIFERENCIAL
Differential Diagnosis
Peripheral Neuropathy
- Burning paresthesias
- No irresistible urge to move
- Sensory deficit on examination
Testes Diagnósticos
- EMG
- Glucose
Nocturnal Cramps
Read more →- Painful muscle contraction
- Relieved with massage
- No urge to move
Testes Diagnósticos
- Clinical examination
Iron Deficiency/Low Ferritin
- Ferritin below 50 ng/mL worsens RLS
- Fatigue, anemia
Testes Diagnósticos
- Serum ferritin
- CBC
Peripheral Arterial Disease
- Claudication on walking (not at rest)
- Diminished pulses
- Cardiovascular factors
Testes Diagnósticos
- Ankle-brachial index
- Doppler
Drug-Induced Akathisia
- Motor restlessness from antipsychotics/metoclopramide
- No circadian rhythm
- Improvement on dose reduction
Testes Diagnósticos
- Medication review
- Improvement after discontinuation
RLS vs. Peripheral Neuropathy and Cramps
Peripheral neuropathy can cause nocturnal leg paresthesias that are mistaken for RLS, but there are important differences. In neuropathy, sensations are usually constant or also present during the day, without the marked circadian rhythm of RLS (worse at night). There is no irresistible urge to move the legs — unlike in RLS, neuropathy symptoms do not improve with movement. Neurologic exam reveals sensory deficit and EMG confirms neuropathy. The two conditions often coexist, since peripheral neuropathy is one of the secondary causes of RLS.
Nocturnal cramps are involuntary, painful, visible muscle contractions during sleep — they differ from RLS by the palpable and visible muscle contraction, by intense localized pain (not the diffuse restlessness of RLS), by relief with massage and muscle stretching (not with continuous movement), and by the absence of the urge to move the legs before falling asleep.
Akathisia and Iron Deficiency: Treatable Causes
Drug-induced akathisia is an often-overlooked diagnosis. Antipsychotics (haloperidol, risperidone), metoclopramide, and other dopaminergic blockers can cause generalized motor restlessness. Unlike RLS, akathisia has no circadian rhythm — it persists throughout the day, also affects the arms and trunk, and improves when the causative medication is reduced or discontinued. A careful medication review is mandatory in every patient with suspected RLS.
Iron deficiency is not only a secondary cause of RLS — it is an aggravating factor even in primary RLS. Ferritin below 50-75 ng/mL compromises CNS dopamine synthesis and worsens symptoms. Iron supplementation is indicated when ferritin is below 75 ng/mL and/or transferrin saturation is below 45%, targeting ferritin above 100 ng/mL (Allen 2018; Silber 2021), even if the CBC shows no anemia. This is the first therapeutic step and may improve cases previously considered refractory.
Peripheral Vascular Disease: The Opposite of RLS
Peripheral arterial disease causes claudication — leg pain on walking that is relieved by rest. This pattern is the exact opposite of RLS, where symptoms appear at rest and are relieved by movement. Clinical distinction is usually straightforward from the history. However, in elderly patients with multiple comorbidities, both conditions may coexist. Diminished peripheral pulses, cardiovascular risk factors, and the ankle-brachial index confirm peripheral arterial disease.
Acupuncture may complement RLS treatment through dopaminergic mechanisms and modulation of spinal excitability. The physician acupuncturist should check ferritin and current medications before starting treatment, since correcting modifiable factors may resolve the condition without additional therapies.
Treatment
The therapeutic approach begins with the correction of contributing factors (iron deficiency, triggering medications) and non-pharmacologic measures. Pharmacologic treatment is reserved for moderate to severe cases that significantly impact sleep and quality of life.
Correction of Factors
Mandatory first stepIron supplementation if ferritin < 75 ng/mL (target > 100 ng/mL). Review medications that worsen RLS: antidepressants (especially SSRIs/SNRIs), antihistamines, antiemetics (metoclopramide). Reduce caffeine and alcohol.
Non-Pharmacologic Measures
ContinuousSleep hygiene, moderate exercise (avoid intense exercise near bedtime), leg massage, pneumatic compression, warm or cold bath before bed. Mentally stimulating activities during inactivity.
Alpha-2-delta ligands
First-line pharmacologic (current guidelines)Gabapentin or pregabalin (gabapentin enacarbil is listed in international guidelines; availability varies by country). Recent guidelines prefer them as first-line because they do not cause augmentation. Useful for sensory symptoms and associated pain. Common side effect: drowsiness (may be beneficial at night). Drug choice should be individualized by the physician.
Dopaminergic Agonists
Second line (low doses)Pramipexole, rotigotine (patch). Effective, but risk of augmentation (paradoxical worsening with prolonged use) in up to 50% of patients within 10 years. Always use the lowest effective dose.
Acupuncture as Treatment
Acupuncture is being investigated as complementary therapy for RLS, with proposed mechanisms that include modulation of dopaminergic neurotransmission, reduction of spinal cord excitability, and improvement of sleep quality through regulation of the autonomic nervous system.
Studies in animal models of RLS have shown that electroacupuncture can increase D2 dopaminergic receptor expression in the spinal cord and modulate the A11 (hypothalamic-spinal) pathway. Stimulating lower-limb points may influence the spinal sensory circuits that are hyperexcitable in RLS.
In clinical practice, acupuncture may be considered as a complementary option, especially in patients with mild to moderate forms, drug intolerance, or in combination with conventional treatment. Clinical reports suggest benefits in sleep quality and reduced symptom frequency.
Prognosis
Primary RLS is a chronic condition, but its course is variable. Some patients have intermittent symptoms with periods of remission, while others show gradual progression. Secondary RLS (iron deficiency, pregnancy) often improves or resolves once the underlying cause is treated.
With proper treatment — correcting iron deficiency, careful medication choice, and behavioral measures — most patients achieve satisfactory symptom control and significantly improved sleep quality.
Myths and Facts
Myth vs. Fact
Restless legs syndrome is anxiety or nervousness.
RLS is a neurologic disorder with a well-defined dopaminergic basis. Although anxiety can coexist and worsen symptoms, RLS has distinct pathophysiologic mechanisms and specific treatment.
Myth vs. Fact
It is just a circulation problem in the legs.
RLS is a disorder of the central nervous system, not a peripheral vascular problem. The confusion arises because venous insufficiency symptoms also worsen at rest, but the circadian pattern and relief with movement distinguish the conditions.
Myth vs. Fact
Children do not have restless legs syndrome.
RLS can begin in childhood and is frequently confused with 'growing pains', ADHD, or anxiety. It is estimated that 2% of school-age children have RLS. Positive family history is even more prevalent in early-onset forms.
When to Seek Help
Frequently Asked Questions
Frequently Asked Questions
Yes, RLS has effective treatment. The first step is to identify and correct secondary causes — especially iron deficiency (ferritin below 75 ng/mL) and medications that worsen the condition. For moderate to severe forms, effective medications include alpha-2-delta ligands (gabapentin, pregabalin) and dopaminergic agonists. Many patients achieve satisfactory control with proper treatment.
The circadian pattern is one of the defining features of RLS. Symptoms worsen at night because dopamine in the central nervous system reaches its lowest levels between 11 PM and 4 AM. Since RLS involves dopaminergic dysfunction, this natural variation creates a window of nocturnal vulnerability. This is why RLS medications are often given in the afternoon or early evening.
Yes, definitely. Low ferritin is one of the most common and treatable causes of RLS. Iron is an essential cofactor for tyrosine hydroxylase, the enzyme needed for brain dopamine synthesis. Even without anemia, ferritin below 50-75 ng/mL may compromise CNS dopamine production. Iron supplementation targeting ferritin above 100 ng/mL may substantially improve symptoms in some patients, sometimes reducing the need for other medications — response is individual and should be evaluated by the physician.
Augmentation is a paradoxical complication of prolonged dopaminergic agonist use for RLS: symptoms begin earlier in the day, spread to the arms, and become more intense — a paradoxical worsening caused by the treatment itself. It occurs in up to 50% of patients after 10 years of use. To avoid it: always use the lowest effective dose, prefer gabapentin/pregabalin as first line (which do not cause augmentation), and monitor regularly.
Yes. RLS can begin in childhood and is frequently confused with "growing pains", ADHD, or anxiety. It is estimated that 2% of school-age children have RLS. Positive family history is even more prevalent in early-onset forms. In children, the diagnosis is more challenging since they have difficulty describing the sensations. The impact on sleep and school performance can be significant.
Moderate, regular exercise can help RLS by improving sleep, reducing stress, and potentially influencing dopaminergic metabolism. However, intense exercise near bedtime may worsen symptoms that night. The recommendation is moderate aerobic exercise in the morning or early afternoon. Stretching and yoga before bed may help some patients.
Acupuncture is being investigated as a complementary option for RLS, with preliminary studies showing benefits in severity scores (IRLS) and sleep quality. Proposed mechanisms include modulation of dopaminergic neurotransmission, reduced spinal excitability, and improved sleep. The physician acupuncturist may consider acupuncture as a complement, especially in mild to moderate forms or in patients who cannot tolerate medications.
There is a link between RLS and the dopaminergic system — both involve dopaminergic dysfunction. Studies show RLS patients have a slightly higher risk of developing Parkinson's disease than the general population, although most never develop it. RLS is not a necessary or mandatory precursor of Parkinson's. Dopaminergic agonists are also used in both conditions, but with different mechanisms and indications.
Yes. RLS occurs in 10-25% of pregnant women, especially in the third trimester. Mechanisms involve relative iron deficiency (increased demand during pregnancy), hormonal changes (estrogen and progesterone), and changes in dopaminergic metabolism. Gestational RLS usually resolves after delivery. Pregnancy management prioritizes iron supplementation and non-pharmacologic measures, since conventional medications have limitations during pregnancy.
Several non-pharmacologic measures can reduce symptoms: strict sleep hygiene (regular schedule, dark, cool room), eliminating caffeine (especially after lunch), reducing alcohol, regular exercise, leg massage before bed, warm or cold bath (depending on individual response), intermittent pneumatic compression, and mentally stimulating activities during inactivity (reading, games) to distract from symptoms.
Related Reading
Deepen your knowledge with related articles